Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Taisuke Kikuchi"'
Autor:
Atsuko Mokubo, Masahiko Takai, Mizuki Kaneshiro, Takehiro Kawata, Akira Kanamori, Yasushi Tanaka, Tetsuo Takuma, Ikuro Matsuba, Akira Kubota, Mitsuo Obana, Shinichi Umezawa, Taisuke Kikuchi, Hideo Machimura, Hiroshi Takeda, Yoko Matsuzawa, Tetsuya Motomiya, Masahiro Takihata, Kotaro Iemitsu, Hajime Maeda, Masaaki Miyakawa, Shogo Ito, Yasuo Terauchi, Taro Asakura
Publikováno v:
Diabetes Technology & Therapeutics. 22:228-234
Background: Sodium/glucose cotransporter-2 (SGLT2) inhibitors improve glycemic control and reduce body weight by increasing glycosuria. Although a compensatory increase of food intake has been repo...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf26c3618f4bfc2903c31e9dcceb01ac
https://doi.org/10.1089/dia.2019.0372
https://doi.org/10.1089/dia.2019.0372
Autor:
Yoshiko Fukunish, Hideki Makino, Haruka Yamamoto, Atsushi Nagai, Taisuke Kikuchi, Koutarou Kajiwara
Publikováno v:
Arerugi: Japanese Journal of Allergology; 2022, Vol. 71 Issue 10, p1214-1219, 6p
Autor:
Hajime Maeda, Tetsuya Motomiya, Takehiro Kawata, Shinichi Umezawa, Kotaro Iemitsu, Akira Kubota, Masaaki Miyakawa, Mizuki Kaneshiro, Masahiko Takai, Mitsuo Obana, Tetsuo Takuma, Hideo Machimura, Hiroshi Takeda, Shogo Ito, Akira Kanamori, Taisuke Kikuchi, Yoko Matsuzawa, Ikuro Matsuba, Yasuo Terauchi, Atsuko Mokubo, Taro Asakura, Masahiro Takihata
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f478f05116b4316eee572e538c60084f
https://doi.org/10.1111/dom.14508/v2/response1
https://doi.org/10.1111/dom.14508/v2/response1
Autor:
Mitsuo Obana, Masaaki Miyakawa, Tetsuya Motomiya, Yasuo Terauchi, Shogo Ito, Taro Asakura, Atsuko Mokubo, Kotaro Iemitsu, Hideo Machimura, Masahiko Takai, Hajime Maeda, Akira Kanamori, Taisuke Kikuchi, Shinichi Umezawa, Akira Kubota, Yoko Matsuzawa, Tetsuo Takuma, Ikuro Matsuba, Masahiro Takihata, Takehiro Kawata, Mizuki Kaneshiro, Hiroshi Takeda
Publikováno v:
Diabetes, obesitymetabolismREFERENCES. 23(12)
Aim Long-term changes in body composition associated with SGLT2 inhibitors have not been characterized. Materials and methods In this multicenter, single-arm, open-label study, 107 subjects with type 2 diabetes were treated, as add-on therapy, with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::544dafbcb687f1443d78fed53ff5c15a
https://pubmed.ncbi.nlm.nih.gov/34338409
https://pubmed.ncbi.nlm.nih.gov/34338409
Autor:
Ikuro Matsuba, Kotaro Iemitsu, Takehiro Kawata, Takashi Iizuka, Masahiro Takihata, Masahiko Takai, Shigeru Nakajima, Nobuaki Minami, Shinichi Umezawa, Akira Kanamori, Hiroshi Takeda, Shogo Ito, Taisuke Kikuchi, Hikaru Amemiya, Mizuki Kaneshiro, Atsuko Mokubo, Tetsuro Takuma, Hideo Machimura, Keiji Tanaka, Taro Asakura, Akira Kubota, Sachio Aoyagi, Kazuhiko Hoshino, Masashi Ishikawa, Mitsuo Obana, Nobuo Sasai, Hideaki Kaneshige, Masaaki Miyakawa, Yasushi Tanaka, Yasuo Terauchi
Publikováno v:
Journal of Endocrinology and Metabolism. 9:151-158
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::884da1cd424a9757aa1e653300fd090b
https://doi.org/10.14740/jem604
https://doi.org/10.14740/jem604
Autor:
Kotaro Iemitsu, Takehiro Kawata, Takashi Iizuka, Masahiro Takihata, Masahiko Takai, Shigeru Nakajima, Nobuaki Minami, Shinichi Umezawa, Akira Kanamori, Hiroshi Takeda, Shogo Ito, Taisuke Kikuchi, Hikaru Amemiya, Mizuki Kaneshiro, Atsuko Mokubo, Tetsuo Takuma, Hideo Machimura, Keiji Tanaka, Taro Asakura, Akira Kubota, Sachio Aoyagi, Kazuhiko Hoshino, Masashi Ishikawa, Yoko Matsuzawa, Mitsuo Obana, Nobuo Sasai, Hideaki Kaneshige, Fuyuki Minagawa, Tatsuya Saito, Kazuaki Shinoda, Masaaki Miyakawa, Yasushi Tanaka, Yasuo Terauchi, Ikuro Matsuba
Publikováno v:
Journal of Endocrinology and Metabolism. 9:51-62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3a89c0f8bb54154266ab7c6a7347e00
https://doi.org/10.14740/jem570
https://doi.org/10.14740/jem570
Autor:
Nobuaki Minami, Shigeru Nakajima, Sachio Aoyanagi, Atsuko Mokubo, Masashi Ishikawa, Masahiro Takihata, Yasushi Tanaka, Takehiro Kawata, Kotaro Iemitsu, Takashi Iizuka, Ikuro Matsuba, Akira Kanamori, Akira Kubota, Kazuaki Shinoda, Taisuke Kikuchi, Mizuki Kaneshiro, Tatsuya Saito, Kazuhiko Hoshino, Keiji Tanaka, Nobuo Sasai, Mitsuo Obana, Masahiko Takai, Hikaru Amemiya, Hideaki Kaneshige, Yoko Matsuzawa, Hiroshi Takeda, Hideo Machimura, Yasuo Terauchi, Taro Asakura, Fuyuki Minagawa, Shinichi Umezawa, Tetsuo Takuma, Masaaki Miyakawa, Shogo Ito
Publikováno v:
Journal of Clinical Medicine Research
Background: Ipragliflozin is a selective sodium glucose co-transporter 2 inhibitor. The ASSIGN-K study is investigating the efficacy and safety of ipragliflozin for type 2 diabetes mellitus (T2DM) in the real-world clinical setting. Methods: Japanese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe58a06d732af9e9b92224743ec1e18b
http://europepmc.org/articles/PMC5544486
http://europepmc.org/articles/PMC5544486
Autor:
Yasushi Tanaka, Ikuro Matsuba, Atsuko Mokubo, Sachio Aoyanagi, Yasuo Terauchi, Hikaru Amemiya, Hiroshi Takeda, Akira Kanamori, Nobuaki Minami, Akira Kubota, Hideaki Kaneshige, Shigeru Nakajima, Yoko Matsuzawa, Hideo Machimura, Kazuaki Shinoda, Takehiro Kawata, Takashi Iizuka, Tatsuya Saito, Mizuki Kaneshiro, Masahiko Takai, Keiji Tanaka, Taro Asakura, Masahiro Takihata, Fuyuki Minagawa, Mitsuo Obana, Masashi Ishikawa, Taisuke Kikuchi, Kazuhiko Hoshino, Kotaro Iemitsu, Nobuo Sasai, Shinichi Umezawa, Shogo Ito, Tetsuo Takuma, Masaaki Miyakawa
Publikováno v:
Journal of Clinical Medicine Research
Background: Ipragliflozin, a sodium-glucose transporter 2 inhibitor, was administered to patients with type 2 diabetes mellitus for 24 weeks to evaluate its effect on glycemic control and body composition. Methods: This was an investigator-initiated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30cd625772e61c8e5682b388e011b2b7
https://doi.org/10.14740/jocmr3038w
https://doi.org/10.14740/jocmr3038w
Autor:
Takehiro Kawata, Takashi Iizuka, Taro Asakura, Fuyuki Minagawa, Hideo Machimura, Nobuo Sasai, Mizuki Kaneshiro, Akira Kanamori, Keiji Tanaka, Akira Kubota, Masaaki Miyakawa, Nobuaki Minami, Shigeru Nakajima, Taisuke Kikuchi, Shogo Ito, Hiroshi Takeda, Kazuaki Shinoda, Kotaro Iemitsu, Yasushi Tanaka, Yasuo Terauchi, Hikaru Amemiya, Masahiko Takai, Hideaki Kaneshige, Tatsuya Saito, Ikuro Matsuba, Yoko Matsuzawa, Mitsuo Obana, Sachio Aoyagi, Kazuhiko Hoshino, Masahiro Takihata, Atsuko Mokubo, Masashi Ishikawa, Shinichi Umezawa, Tetsuo Takuma
Publikováno v:
Journal of Clinical Medicine Research
Background: Ipragliflozin is a sodium-glucose co-transporter 2 inhibitor that can improve glycemic control and reduce body weight and blood pressure in patients with type 2 diabetes mellitus (T2DM). We evaluated the efficacy and safety of ipraglifloz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5de40dab22792eb2590119096d69bcf5
http://europepmc.org/articles/PMC4701067
http://europepmc.org/articles/PMC4701067
Autor:
Akira Kanamori, Taro Asakura, Masahiko Takai, Masashi Ishikawa, Yasushi Tanaka, Nobuaki Minami, Akira Kubota, Nobuo Sasai, Hideo Machimura, Shigeru Nakajima, Ikuro Matsuba, Masaaki Miyakawa, Yasuo Terauchi, Hikaru Amemiya, Mizuki Kaneshiro, Kazuhiko Hoshino, Hideaki Kaneshige, Hiroshi Takeda, Tetsuro Takuma, Keiji Tanaka, Shinichi Umezawa, Kotaro Iemitsu, Sachio Aoyagi, Atsuko Mokubo, Shogo Ito, Mitsuo Obana, Taisuke Kikuchi, Takehiro Kawata, Takashi Iizuka, Masahiro Takihata
Publikováno v:
Journal of Clinical Medicine Research
Background: Ipragliflozin is a selective sodium glucose co-transporter 2 (SGLT2) inhibitor that blocks glucose reabsorption in the proximal tubules. SGLT2 inhibitors are expected to be effective in patients with insulin resistance and obesity, but it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8409387c06446f2134869f8c7de8e0
https://pubmed.ncbi.nlm.nih.gov/27081422
https://pubmed.ncbi.nlm.nih.gov/27081422